TCN 201 100mg 100mg | Purity Not Available
Adooq Bioscience
TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier PageTCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier PageTCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
More Information Supplier PageOC 000459 is a potent, oral and selective CRTH2 (also known as DP2) antagonist.
More Information Supplier PageOC 000459 is a potent, oral and selective CRTH2 (also known as DP2) antagonist.
More Information Supplier PageOC 000459 is a potent, oral and selective CRTH2 (also known as DP2) antagonist.
More Information Supplier PageOC 000459 is a potent, oral and selective CRTH2 (also known as DP2) antagonist.
More Information Supplier PageAP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageAP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageZotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.
More Information Supplier PageZotarolimus is an immunosuppressant. It is a semi-synthetic derivative of rapamycin. It was designed for use in stents with phosphorylcholine as a carrier.
More Information Supplier Page